FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update Click here to view original post
The company, founded 11 years ago, will receive $250 million upfront from its Southern California buyer. Click here to view original post
Integrated polygenic risk score more accurately identified individuals at elevated risk for developing coronary artery disease, especially within borderline or intermediate clinical risk categories and for South Asian individuals MENLO PARK, Calif., Nov. 2, 2023 […]
The FDA is pausing patient enrollment and screening for Nurix Therapeutics’ Phase I clinical trial for a potential drug to treat B-cell malignancies in cancer patients. The agency is halting the trial after Nurix told […]
The rare disease drug developer is turning to former Genentech head Alexander Hardy as the launch of its Roctavian gene therapy stumbles. Click here to view original post
The company will move its headquarters back to the East Bay, where it had been based for two decades. Click here to view original post
Terremoto Biosciences has reeled in $175 million to create small molecules based on work from Principia Biopharma co-founder Jack Taunton and Global Blood Therapeutics co-founder Matthew Jacobson. Jack Taunton The Series B arrives 18 months […]
Komodo Health Delivers In-Depth and Actionable Patient-Level Insights for Enterprise Customers with its Robust Real-world Data, Advanced Analytics and AI-powered Algorithms, and Clinical and Industry Expertise SAN ANTONIO and SAN FRANCISCO, Nov. 2, 2023 /PRNewswire/ […]
As a member AbbVie’s Biologics Discovery Sciences, you will play a key role in the production and characterization of antibody-based… Click here to view original post
Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are once again enveloping the Pharmalot campus, where the official mascots… Click here to view original […]
Copyright © 2023 Biotech Networks, LLC
